In addition, Eisai must conduct a post-authorization safety study, including setting up a patient registry for the European Union. Now each European country must set its own rules for access and ...

As lecanemab gains regulatory approval in more countries (see previous story), clinicians are eager to learn from the first centers to have incorporated this therapeutic antibody into their clinical ...

Conference after conference, Roche scientists running the ongoing Brain Shuttle AD trial of trontinemab are dispensing ...

Do you know a conference you think we should list? Let us know by sending us an email with the details to [email protected].

B.A., English, University of Florida M.B.A., American Jewish University Ed.D., Organization of Leadership and Gerontology, Nova Southeastersn University ...

A biobank with fresh and formalin-fixed specimens specializing in neurogenerative disease research.

Average Award $300,000-$350,000 based on stage and scope of research. Slightly higher budgets can be considered. One year with potential for follow-on funding.